1. Home
  2. FAMI vs BRTX Comparison

FAMI vs BRTX Comparison

Compare FAMI & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmmi Inc.

FAMI

Farmmi Inc.

N/A

Current Price

$1.32

Market Cap

7.8M

ML Signal

N/A

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$0.22

Market Cap

9.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAMI
BRTX
Founded
2015
1997
Country
China
United States
Employees
N/A
N/A
Industry
Packaged Foods
Managed Health Care
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
9.3M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
FAMI
BRTX
Price
$1.32
$0.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.9K
5.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
66.08
EPS
N/A
N/A
Revenue
N/A
$81,000.00
Revenue This Year
N/A
$24.64
Revenue Next Year
N/A
$287.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.19
52 Week High
$2.22
$2.10

Technical Indicators

Market Signals
Indicator
FAMI
BRTX
Relative Strength Index (RSI) 48.83 19.51
Support Level $1.30 $0.19
Resistance Level $1.36 $0.29
Average True Range (ATR) 0.07 0.03
MACD 0.01 0.02
Stochastic Oscillator 47.37 24.98

Price Performance

Historical Comparison
FAMI
BRTX

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: